Literature DB >> 9563728

Alveolar macrophages from atopic asthmatics, but not atopic nonasthmatics, enhance interleukin-5 production by CD4+ T cells.

C Tang1, J M Rolland, X Li, C Ward, R Bish, E H Walters.   

Abstract

Recent studies have demonstrated that different antigen-presenting cell (APC)-related factors in the microenvironment of a T cell may determine its profile and quantity of cytokine expression and production. We have therefore examined the effects of alveolar macrophages and peripheral blood monocytes on interleukin (IL)-5 production by peripheral blood CD4+ T cells from atopic people with asthma (AA), atopic people without asthma (AN), and nonatopic normal subjects (N). In response to allergen stimulation, IL-5 production was significantly enhanced by the addition of monocytes to CD4+ cell cultures in AA and AN patients (p < 0.05 and 0.01, respectively), but not in N subjects. In mitogen-stimulated CD4+ cell plus monocyte cocultures, there was a small increase in IL-5 production in all three groups (p < 0.05 for AN). In contrast, the addition of alveolar macrophages to parallel cultures significantly amplified IL-5 production only in AA patients (p < 0.05 or 0.01). Furthermore, IL-5 production by CD4+ cells in alveolar macrophage cocultures, stimulated by allergen or mitogen, was higher than that in monocyte cocultures in AA patients (p < 0.05). Conversely, in AN and N subjects, the IL-5 values for alveolar macrophage cocultures were lower than those for peripheral blood monocytes. In blocking studies, antibodies against IL-1alpha, IL-1beta, IL-6, or tumor necrosis factor-alpha differentially suppressed macrophage-enhanced IL-5 production (p < 0.05 for IL-1beta and IL-6) and expression of the activation marker CD25 (p < 0.05 for IL-1alpha and IL-6) by allergen-stimulated CD4+ cells in AA patients. These observations suggest that alveolar macrophages influence the quantity of IL-5 production by T cells in the airways and, as a consequence, the development of asthma in atopic individuals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563728     DOI: 10.1164/ajrccm.157.4.9706118

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  8 in total

1.  Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma.

Authors:  Cristan Herbert; Melissa M Scott; Kim H Scruton; Rylie P Keogh; Kristy C Yuan; Kenneth Hsu; Jessica S Siegle; Nicodemus Tedla; Paul S Foster; Rakesh K Kumar
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Reduced production of interleukin 12 by interferon gamma primed alveolar macrophages from atopic asthmatic subjects.

Authors:  M J Plummeridge; L Armstrong; M A Birchall; A B Millar
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

3.  Alveolar macrophages modulate allergic inflammation in a murine model of asthma.

Authors:  Bo Ram Bang; Eunyoung Chun; Eun Jin Shim; Hyun Seung Lee; Soo Yeon Lee; Sang Heon Cho; Kyung Up Min; You Young Kim; Heung Woo Park
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

Review 4.  Biology of lung macrophages in health and disease.

Authors:  Helena Aegerter; Bart N Lambrecht; Claudia V Jakubzick
Journal:  Immunity       Date:  2022-09-13       Impact factor: 43.474

5.  Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2.

Authors:  G Ménard; V Turmel; E Y Bissonnette
Journal:  Clin Exp Immunol       Date:  2007-09-05       Impact factor: 4.330

Review 6.  Allergen-Specific CD4(+) T Cells in Human Asthma.

Authors:  Morris F Ling; Andrew D Luster
Journal:  Ann Am Thorac Soc       Date:  2016-03

Review 7.  Maternal influence in the transmission of asthma susceptibility.

Authors:  Edward G Barrett
Journal:  Pulm Pharmacol Ther       Date:  2007-07-12       Impact factor: 3.410

8.  Alveolar macrophages are sentinels of murine pulmonary homeostasis following inhaled antigen challenge.

Authors:  S A Mathie; K L Dixon; S A Walker; V Tyrrell; M Mondhe; V B O'Donnell; L G Gregory; C M Lloyd
Journal:  Allergy       Date:  2014-11-28       Impact factor: 13.146

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.